The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clouse, K. A.
Right arrow Articles by Folks, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clouse, K. A.
Right arrow Articles by Folks, T. M.

The Journal of Immunology, Vol 142, Issue 2 431-438, Copyright © 1989 by American Association of Immunologists

ARTICLES

Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone

KA Clouse, D Powell, I Washington, G Poli, K Strebel, W Farrar, P Barstad, J Kovacs, AS Fauci and TM Folks
Georgetown University, Department of Microbiology, Washington, D.C. 20007.

A T cell clone (ACH-2) derived from T cells infected with HIV-1 was found to produce HIV-1 in response to stimulation with a monokine- enriched supernatant prepared by culturing human monocyte/macrophages with bacterial LPS (LPS-MO SN). Monokine induction of ACH-2 cells resulted in augmented virus production reflected by an increase in reverse transcriptase activity and in the synthesis of all major viral proteins. Examination of the cells by indirect immunofluorescence revealed that 10 to 15% of uninduced cells constitutively expressed HIV proteins, whereas 100% showed positive immunofluorescence in response to LPS-MO SN. This induction of virus by LPS-MO SN resulted in approximately a 100-fold increase of infectious virus production over uninduced ACH-2 cells. LPS alone could not induce HIV-1 expression, whereas LPS-MO SN resulted in the greatest virus expression. Cell separation studies confirmed the source of the inducing factor(s) to be cells bearing the mature monocyte/macrophage marker, Leu M3. Biochemical fractionation of the LPS-MO SN suggested that one or more factors, having apparent Mr of approximately 45 kDa, were involved in this induction. Absorption of the LPS-MO SN with immunoaffinity gels specific for human TNF-alpha was shown to completely remove the HIV inducing activity for the ACH-2 cell line.


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
S. Abdurahman, A. Vegvari, M. Youssefi, M. Levi, S. Hoglund, E. Andersson, P. Horal, B. Svennerholm, J. Balzarini, and A. Vahlne
Activity of the Small Modified Amino Acid {alpha}-Hydroxy Glycineamide on In Vitro and In Vivo Human Immunodeficiency Virus Type 1 Capsid Assembly and Infectivity
Antimicrob. Agents Chemother., October 1, 2008; 52(10): 3737 - 3744.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. Shuck-Lee, F. F. Chen, R. Willard, S. Raman, R. Ptak, M.-L. Hammarskjold, and D. Rekosh
Heterocyclic Compounds That Inhibit Rev-RRE Function and Human Immunodeficiency Virus Type 1 Replication
Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3169 - 3179.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Lin and B. R. Cullen
Analysis of the Interaction of Primate Retroviruses with the Human RNA Interference Machinery
J. Virol., November 15, 2007; 81(22): 12218 - 12226.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. Benki, R. S. McClelland, S. Emery, J. M. Baeten, B. A. Richardson, L. Lavreys, K. Mandaliya, and J. Overbaugh
Quantification of Genital Human Immunodeficiency Virus Type 1 (HIV-1) DNA in Specimens from Women with Low Plasma HIV-1 RNA Levels Typical of HIV-1 Nontransmitters
J. Clin. Microbiol., December 1, 2006; 44(12): 4357 - 4362.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. A. Arlen, D. G. Brooks, L. Y. Gao, D. Vatakis, H. J. Brown, and J. A. Zack
Rapid Expression of Human Immunodeficiency Virus following Activation of Latently Infected Cells
J. Virol., February 1, 2006; 80(3): 1599 - 1603.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Soret, N. Bakkour, S. Maire, S. Durand, L. Zekri, M. Gabut, W. Fic, G. Divita, C. Rivalle, D. Dauzonne, et al.
Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors
PNAS, June 14, 2005; 102(24): 8764 - 8769.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
C. Drosten, E. Muller-Kunert, M. Dietrich, J. Gerdes, and H. Schmitz
Topographic and Quantitative Display of Integrated Human Immunodeficiency Virus-1 Provirus DNA in Human Lymph Nodes by Real-Time Polymerase Chain Reaction
J. Mol. Diagn., May 1, 2005; 7(2): 219 - 225.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Devadas, N. J. Hardegen, L. M. Wahl, I. K. Hewlett, K. A. Clouse, K. M. Yamada, and S. Dhawan
Mechanisms for Macrophage-Mediated HIV-1 Induction
J. Immunol., December 1, 2004; 173(11): 6735 - 6744.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
V. Krishnan and S. L. Zeichner
Host Cell Gene Expression during Human Immunodeficiency Virus Type 1 Latency and Reactivation and Effects of Targeting Genes That Are Differentially Expressed in Viral Latency
J. Virol., September 1, 2004; 78(17): 9458 - 9473.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Sagar, L. Lavreys, J. M. Baeten, B. A. Richardson, K. Mandaliya, B. H. Chohan, J. K. Kreiss, and J. Overbaugh
Infection with Multiple Human Immunodeficiency Virus Type 1 Variants Is Associated with Faster Disease Progression
J. Virol., December 1, 2003; 77(23): 12921 - 12926.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. H. Hamer, S. Bocklandt, L. McHugh, T.-W. Chun, P. M. Blumberg, D. M. Sigano, and V. E. Marquez
Rational Design of Drugs That Induce Human Immunodeficiency Virus Replication
J. Virol., October 1, 2003; 77(19): 10227 - 10236.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Kao, H. Akari, M. A. Khan, M. Dettenhofer, X.-F. Yu, and K. Strebel
Human Immunodeficiency Virus Type 1 Vif Is Efficiently Packaged into Virions during Productive but Not Chronic Infection
J. Virol., December 20, 2002; 77(2): 1131 - 1140.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
U. O'Doherty, W. J. Swiggard, D. Jeyakumar, D. McGain, and M. H. Malim
A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration
J. Virol., October 2, 2002; 76(21): 10942 - 10950.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. Vandegraaff, R. Kumar, C. J. Burrell, and P. Li
Kinetics of Human Immunodeficiency Virus Type 1 (HIV) DNA Integration in Acutely Infected Cells as Determined Using a Novel Assay for Detection of Integrated HIV DNA
J. Virol., November 15, 2001; 75(22): 11253 - 11260.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
S. D. Lawn, S. T. Butera, and T. M. Folks
Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection
Clin. Microbiol. Rev., October 1, 2001; 14(4): 753 - 777.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
N. Vandegraaff, R. Kumar, H. Hocking, T. R. Burke Jr., J. Mills, D. Rhodes, C. J. Burrell, and P. Li
Specific Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Integration in Cell Culture: Putative Inhibitors of HIV-1 Integrase
Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2510 - 2516.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Wang, C. de la Fuente, L. Deng, L. Wang, I. Zilberman, C. Eadie, M. Healey, D. Stein, T. Denny, L. E. Harrison, et al.
Inhibition of Human Immunodeficiency Virus Type 1 Transcription by Chemical Cyclin-Dependent Kinase Inhibitors
J. Virol., August 15, 2001; 75(16): 7266 - 7279.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. Takahashi, Y. Tanaka, A. Yamashita, Y. Koyanagi, M. Nakamura, and N. Yamamoto
OX40 Stimulation by gp34/OX40 Ligand Enhances Productive Human Immunodeficiency Virus Type 1 Infection
J. Virol., August 1, 2001; 75(15): 6748 - 6757.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J.-P. Lai, W.-Z. Ho, G.-X. Zhan, Y. Yi, R. G. Collman, and S. D. Douglas
Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes
PNAS, March 27, 2001; 98(7): 3970 - 3975.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Kameoka, L. Rong, M. Götte, C. Liang, R. S. Russell, and M. A. Wainberg
Role for Human Immunodeficiency Virus Type 1 Tat Protein in Suppression of Viral Reverse Transcriptase Activity during Late Stages of Viral Replication
J. Virol., March 15, 2001; 75(6): 2675 - 2683.
[Abstract] [Full Text]

Home page
 Microbiol. Mol. Biol. Rev.Home page
K. Ikuta, S. Suzuki, H. Horikoshi, T. Mukai, and R. B. Luftig
Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis
Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 725 - 745.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Baba, M. Okamoto, and H. Takeuchi
Inhibition of Human Immunodeficiency Virus Type 1 Replication in Acutely and Chronically Infected Cells by EM2487, a Novel Substance Produced by a Streptomyces Species
Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2350 - 2355.
[Abstract] [Full Text]

Home page
 NEJMHome page
M. R. Furtado, D. S. Callaway, J. P. Phair, K. J. Kunstman, J. L. Stanton, C. A. Macken, A. S. Perelson, and S. M. Wolinsky
Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy
N. Engl. J. Med., May 27, 1999; 340(21): 1614 - 1622.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
D. D. Panteleeff, G. John, R. Nduati, D. Mbori-Ngacha, B. Richardson, J. Kreiss, and J. Overbaugh
Rapid Method for Screening Dried Blood Samples on Filter Paper for Human Immunodeficiency Virus Type 1 DNA
J. Clin. Microbiol., February 1, 1999; 37(2): 350 - 353.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
P. R. Gorry, J. L. Howard, M. J. Churchill, J. L. Anderson, A. Cunningham, D. Adrian, D. A. McPhee, and D. F. J. Purcell
Diminished Production of Human Immunodeficiency Virus Type 1 in Astrocytes Results from Inefficient Translation of gag, env, and nef mRNAs despite Efficient Expression of Tat and Rev
J. Virol., January 1, 1999; 73(1): 352 - 361.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
H. Zhang, G. Dornadula, M. Beumont, L. Livornese, B. Van Uitert, K. Henning, and R. J. Pomerantz
Human Immunodeficiency Virus Type 1 in the Semen of Men Receiving Highly Active Antiretroviral Therapy
N. Engl. J. Med., December 17, 1998; 339(25): 1803 - 1809.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Z. Nie, D. Bergeron, R. A. Subbramanian, X.-J. Yao, F. Checroune, N. Rougeau, and E. A. Cohen
The Putative Alpha Helix 2 of Human Immunodeficiency Virus Type 1 Vpr Contains a Determinant Which Is Responsible for the Nuclear Translocation of Proviral DNA in Growth-Arrested Cells
J. Virol., May 1, 1998; 72(5): 4104 - 4115.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. El Kharroubi, G. Piras, R. Zensen, and M. A. Martin
Transcriptional Activation of the Integrated Chromatin-Associated Human Immunodeficiency Virus Type 1 Promoter
Mol. Cell. Biol., May 1, 1998; 18(5): 2535 - 2544.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
R. Bernier, B. Barbeau, M. J. Tremblay, and M. Olivier
The Lipophosphoglycan of Leishmania donovani Up-Regulates HIV-1 Transcription in T Cells Through the Nuclear Factor-{kappa}B Elements
J. Immunol., March 15, 1998; 160(6): 2881 - 2888.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. K. De, C. N.S. Venkateshan, P. Seth, D. Carleton Gajdusek, and C. J. Gibbs Jr
Adenovirus-Mediated Human Immunodeficiency Virus-1 Nef Expression in Human Monocytes/Macrophages and Effect of Nef on Downmodulation of Fcgamma Receptors and Expression of Monokines
Blood, March 15, 1998; 91(6): 2108 - 2117.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. A. Turpin, R. W. Buckheit Jr., D. Derse, M. Hollingshead, K. Williamson, C. Palamone, M. C. Osterling, S. A. Hill, L. Graham, C. A. Schaeffer, et al.
Inhibition of Acute-, Latent-, and Chronic-Phase Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Bistriazoloacridone Analog That Selectively Inhibits HIV-1 Transcription
Antimicrob. Agents Chemother., March 1, 1998; 42(3): 487 - 494.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
B. Barbeau, R. Bernier, N. Dumais, G. Briand, M. Olivier, R. Faure, B. I. Posner, and M. Tremblay
Activation of HIV-1 Long Terminal Repeat Transcription and Virus Replication via NF-kappa B-dependent and -independent Pathways by Potent Phosphotyrosine Phosphatase Inhibitors, the Peroxovanadium Compounds
J. Biol. Chem., May 16, 1997; 272(20): 12968 - 12977.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. I. Rivas, J. C. Vera, V. H. Guaiquil, F. V. Velasquez, O. A. Borquez-Ojeda, J. G. Carcamo, I. I. Concha, and D. W. Golde
Increased Uptake and Accumulation of Vitamin C in Human Immunodeficiency Virus 1-infected Hematopoietic Cell Lines
J. Biol. Chem., February 28, 1997; 272(9): 5814 - 5820.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
J. K. Lazdins, M. Grell, M. R. Walker, K. Woods-Cook, P. Scheurich, and K. Pfizenmaier
Membrane Tumor Necrosis Factor (TNF) Induced Cooperative Signaling of TNFR60 and TNFR80 Favors Induction of Cell Death Rather Than Virus Production in HIV-infected T Cells
J. Exp. Med., January 1, 1997; 185(1): 81 - 90.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
W. G. Rice, J. G. Supko, L. Malspeis, R. W. Buckheit Jr., D. Clanton, M. Bu, L. Graham, C. A. Schaeffer, J. A. Turpin, J. Domagala, et al.
Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS
Science, November 17, 1995; 270(5239): 1194 - 1197.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
S. Legrand-Poels, V. Bours, B. Piret, M. Pflaum, B. Epe, B. Rentier, and J. Piette
Transcription Factor NF-kappaB Is Activated by Photosensitization Generating Oxidative DNA Damages
J. Biol. Chem., March 24, 1995; 270(12): 6925 - 6934.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
P G Babu, B D Rawal, H Khayam-Bashi, and G N Vyas
Detection of exceedingly low levels of HIV proviral DNA in multimillion peripheral blood mononuclear cells by PCR.
Genome Res., August 1, 1993; 3(1): 63 - 64.
[PDF]

Home page
 ScienceHome page
M. Garcia-Blanco and B. Cullen
Molecular basis of latency in pathogenic human viruses
Science, November 8, 1991; 254(5033): 815 - 820.
[Abstract] [PDF]

Home page
 ScienceHome page
G Poli, J. Orenstein, A Kinter, T. Folks, and A. Fauci
Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines
Science, May 5, 1989; 244(4904): 575 - 577.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
L.-M. Huang, M.-F. Chao, M.-Y. Chen, H.-m. Shih, Y.-P. Chiang, C.-Y. Chuang, and C.-Y. Lee
Reciprocal Regulatory Interaction between Human Herpesvirus 8 and Human Immunodeficiency Virus Type 1
J. Biol. Chem., April 13, 2001; 276(16): 13427 - 13432.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.